Novartis Investigative Site
Hartford, Connecticut 06106
We've found
6 trials
at this facility
Neoplasms, Breast Clinical Trial
Updated: 4/4/2016
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling,
Phase
IV
Updated: 4/4/2016
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 9/21/2015
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids
Status: Enrolling,
Phase
III
Updated: 9/21/2015
Click here to add this to my saved trials
Rheumatology Clinical Trial
Updated: 12/31/1969
Secukinumab Safety and Efficacy in JPsA and ERA
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Updated: 12/31/1969
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials